Printer Friendly

Browse T cells topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Kite Pharmas CAR T-cell Therapy Production Facility. May 20, 2019 283
Syncona Establishes New Cell Therapy Firm With GBP35 Million Financing. May 20, 2019 220
New findings could be used as vaccination strategy for sexually transmitted infections. May 18, 2019 425
Portugal : First treatments with gene therapy of CAR T cells advance in Portugal. May 18, 2019 267
Adaptimmune announces license agreement with Alpine Immune Sciences. May 15, 2019 168
Shenfu injection prolongs survival and protects the intestinal mucosa in rats with sepsis by modulating immune response. Jin, Shuifang; Jiang, Ronglin; Lei, Shu; Jin, Liming; Zhu, Chen; Feng, Wen; Shen, Yingying Report May 11, 2019 4719
Tmunity Therapeutics signs exclusive licensing and research collaboration with the University of California San Francisco. May 3, 2019 211
Tmunity Therapeutics signs exclusive licensing and research collaboration with the University of California San Francisco. May 3, 2019 207
Seattle Genetics: Health Canada approves use of Adcetris, AVD chemotherapy. May 3, 2019 126
United States : Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities. May 2, 2019 219
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA. May 1, 2019 656
Celgene, bluebird bio report interim results from CRB-401 study. May 1, 2019 441
Raised levels of IFN-gamma and IL-13 are associated with pre-diabetes amongst newly diagnosed patients with Tuberculosis. Report Apr 30, 2019 4095
HYPER IMMUNOGLOBULIN E IGE SYNDROME (HIES) WITH PARTIAL T LYMPHOCYTES DEFICIENCY. Apr 30, 2019 1431
Kite Plans New Facility to Expand Cell Therapy Production Capabilities. Apr 29, 2019 251
LineaRX says Avectas collaboration leads to increase in transfection. Apr 29, 2019 278
Genexine, NeoImmuneTech Dose First Patient in the Combination Trial of Hyleukin-7 with Merck's Keytruda in Triple-Negative Breast Cancer. Apr 29, 2019 699
Kite plans for new Maryland facility. Apr 26, 2019 208
Kite plans for new Maryland facility. Apr 26, 2019 204
Gilead Sciences (NASDAQ: GILD) - Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities -- 24/4/2019. Apr 25, 2019 1317
TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients. Apr 25, 2019 445
Creating a bovine C-type lectin receptor atlas and identification of their ligands. Apr 25, 2019 377
United States : St. Jude gene therapy cures babies with 'bubble boy' disease. Apr 20, 2019 773
Belgium : Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency. Apr 20, 2019 420
Precision BioSciences doses first patient in PBCAR0191 Phase 1/2a clinical trial. Apr 17, 2019 161
Tessa partners with Merck to evaluate its human papillomavirus-specific T cell (HPVST) therapy & KEYTRUDA combination for cervical cancer. Apr 16, 2019 318
Tessa partners with Merck to evaluate its human papillomavirus-specific T cell (HPVST) therapy & KEYTRUDA combination for cervical cancer. Apr 16, 2019 314
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Vitamin D's 'dramatic' impact on MS susceptibility revealed by scientists; Researchers at the University of Edinburgh say their study has shed light on how vitamin D deficiency may influence the risk of autoimmune diseases. Apr 15, 2019 600
Allogene Therapeutics announces publication of ALLO-715 study results. Report Apr 15, 2019 131
Takara Bio submits Drug Master File to FDA for RetroNectin GMP grade liquid format for development of cancer immunotherapies. Apr 12, 2019 157
Takara Bio submits Drug Master File to FDA for RetroNectin GMP grade liquid format for development of cancer immunotherapies. Apr 12, 2019 161
Applied DNA's LineaRx achieves anti-CD19 CAR expression in human T cells. Apr 8, 2019 186
Janssen's Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency. Apr 8, 2019 560
Immunomic Therapeutics Presents Late-Breaking Preclinical Data on DNA Vaccine ITI-7000 at AACR 2019. Apr 4, 2019 584
IMV Inc. presents preclinical research for immunotherapy program at AACR. Apr 3, 2019 303
Contract Manufacturing Organization For Advanced Therapy Medicinal Products (atimp). Apr 3, 2019 468
Inovio says dBiTEs generated potent anti-tumor activities in preclinical study. Report Apr 2, 2019 142
Aptevo Therapeutics presents preclinical data on APVO436, ALG.APV-527 at AACR. Clinical report Apr 2, 2019 359
Jounce Therapeutics reports new clinical data on vopratelimab. Apr 2, 2019 355
Imbrium Therapeutics Gains US FDA Orphan Drug Designation for Tinostamustine for the Treatment of T-cell Prolymphocytic Leukemia. Apr 2, 2019 592
TC BioPharm welcomes John Anderson as scientific and medical director. Apr 1, 2019 176
TC BioPharm welcomes John Anderson as scientific and medical director. Apr 1, 2019 172
Iovance Biotherapeutics presents data on T-cell diversity at AACR meeting. Clinical report Apr 1, 2019 164
Fate Therapeutics presents data on clonal master engineered iPSC lines. Apr 1, 2019 145
Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients/Tedavi Naif HIV/AIDS Hastalarinda Kullanilan Antiretroviral Tedavi Rejimlerinin Virolojik ve Immunolojik Yanit Acisindan Karsilastirilmasi. Akkaya-Isik, Sinem; Gunduz, Alper; Oncul, Ahsen; Hamidi, Aziz Ahmad; Yildiz-Sevgi, Dilek; Kes-Uzun, Apr 1, 2019 4233
Sheba, Lonza Collaborate on Cell Therapy Mfg. Platform. Apr 1, 2019 172
Atara's collaborator presents Phase 1 study results in Advanced Mesothelioma. Mar 31, 2019 373
Boy fighting rare cancer finally finds stem cell donor match after 10,000 offers; Oscar Saxelby-Lee was in a race against time to find a life-saving match after he was diagnosed with rare cancer T-cell acute lymphoblastic leukaemia (T-ALL). Mar 30, 2019 526
Advaxis Granted US Patent Relating to Axalimogene Filolisbac. Mar 26, 2019 400
Lead Pharma triggers fourth milestone payment under its license & collaboration agreement with Sanofi. Mar 21, 2019 234
Crimson Trace CTL-3420 4-20X 50mm. Hutchcroft, Joel J. Product/service evaluation Mar 20, 2019 419
The integration of human T cell senescence and function at the molecular level. Mar 18, 2019 517
Exploring the role of T cells in the immune surveillance of early renal cancer. Mar 13, 2019 544
United States : Cancer Therapy Company Cellectis to Establish Manufacturing Operations in North Carolina. Mar 8, 2019 741
Germany : New immune therapy for treating cancer. Mar 7, 2019 762
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral Vectors. Mar 5, 2019 201
Level of serum soluble Tim-3 expression in early-phase acute pancreatitis. Lin, Min; Huang, Jin; Huang, Jian; Liu, Sheng-lan; Chen, Wei-Chang Report Mar 1, 2019 2921
Hidradenitis suppurativa linked to increased lymphoma risk. Sullivan, Michele G. Mar 1, 2019 432
Nektar 'excited' by preliminary data from REVEAL study. Mar 1, 2019 205
SARTORIUS BIOSTAT SINGLE-USE BIOREACTOR. Mar 1, 2019 379
Sartorius Launches BIOSTAT Single-Use Bioreactor: Constantia Flexibles introduces Flexible Blister packaging. Mar 1, 2019 382
New Way in Cancer Therapy: PD-1 Inhibitors and Hematologic Diseases. Akyol, Gulsah; Kaynar, Leylagul; Cetin, Mustafa Report Mar 1, 2019 4443
SLC30A8 Gene rs13266634 C/T Polymorphism in Children with Type 1 Diabetes in Tamil Nadu, India. Thirunavukkarasu, Ramasamy; Asirvatham, Arthur Joseph; Chitra, Ayyappan; Jayalakshmi, Mariakuttikan Report Mar 1, 2019 3492
Cutaneous Pseudolymphoma Due to Hirudotherapy/Hirudoterapiye Bagli Kutanoz Psodolenfoma. Temiz, Selami Aykut; Ozer, Ilkay; Ataseven, Arzu; Dursun, Recep; Findik, Siddika Case study Mar 1, 2019 1479
Cell Medica Awarded 8.7m CPRIT Grant to Accelerate CMD-502 Off-the-shelf CAR-NKT Cell Therapy into Clinical Development. Feb 27, 2019 546
TC BioPharm Partners & Trinity College Dublin partnership to develop V Delta 1 I[superscript three]I' T cell-based cancer treatments. Feb 25, 2019 195
TC BioPharm Partners & Trinity College Dublin partnership to develop V Delta 1 I[superscript three]I' T cell-based cancer treatments. Feb 25, 2019 191
Mallinckrodt announces research collaboration agreement with Transimmune AG. Feb 25, 2019 124
Effect of antigen dose on T cells that signal via pSTAT but that are unresponsive to JAK inhibition a mechanism of T cell autoimmune activation. Feb 23, 2019 108
Regulatory T cell Immunobiology Specialization and Stability in mucosal immunoregulation and tissue homestasis. Feb 23, 2019 108
United States : Provectus Announces Grant of Orphan Drug Designation in U.S. to PV-10 for Treatment of Ocular Melanoma. Feb 23, 2019 365
The Complement System and iNKT Cell Response. Feb 22, 2019 471
Germany : Salt could be a key factor. Feb 22, 2019 360
Mallinckrodt elects to discontinue further enrollment in Uvadex, Therakos trial. Feb 20, 2019 232
Expensive CAR-T Cancer Therapy Could Be Part Of Medicare Coverage. Feb 20, 2019 290
Autolus says updated CARPALL trial results confirm AUTO1 data from ASH 2017. Feb 19, 2019 394
'Killer' cells raise hope of universal flu vaccine. Feb 19, 2019 370
Germany : Loss of identity in immune cells explained. Feb 19, 2019 491
T cells in tuberculosis: What type of T cell mediates immunity and how do we induce it by vaccination. Feb 15, 2019 427
NeoTX Therapeutics signs clinical collaboration with MedImmune. Feb 13, 2019 240
Researchers find clues to a functional HIV cure. Feb 8, 2019 377
Cytonus Develops New Cell-Based Technology to Advance the Fight against Cancer and Inflammatory Diseases. Feb 6, 2019 346
Renewable Source Of Cancer-Fighting T Cells From New Technique. Feb 4, 2019 679
Renewable Source Of Cancer-Fighting T Cells From New Technique. Feb 4, 2019 585
Single mom appeals anew for cancer-stricken son. Feb 4, 2019 250
Researchers find new clues to control HIV. Feb 2, 2019 616
Tissue Resident Memory (Trm) CD8+ T cells: Genome-wide dissection of cellular differentiation and heterogeneity. Feb 2, 2019 327
Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment. Feb 2, 2019 327
Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology. Feb 2, 2019 350
USFDA approves Eureka Therapeutics investigational new drug for ET140202 ARTEMIS T-cell therapy. Feb 1, 2019 157
USFDA approves Eureka Therapeutics investigational new drug for ET140202 ARTEMIS T-cell therapy. Feb 1, 2019 153
Engineering a Complex TCR Immunotherapy. Feb 1, 2019 508
FDA CLEARS ET140202 ARTEMIS T-CELL THERAPY TRIAL. Feb 1, 2019 388
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans. McElroy, Anita K.; Shrivastava-Ranjan, Punya; Harmon, Jessica R.; Martines, Roosecelis B.; Silva-Fla Report Feb 1, 2019 6211
The effect of nanoemulsified methionine and cysteine on the in vitro expression of casein in bovine mammary epithelial cells. Kim, Tae-Il; Kim, Tae-Gyun; Lim, Dong-Hyun; Kim, Sang-Bum; Park, Seong-Min; Lim, Hyun-Joo; Kim, Hyun Report Feb 1, 2019 4335
Six-year-old boy with mediastinal mass. Rehman, Palwasha; Wali, Rabia Muhammad Clinical report Jan 31, 2019 474
Manipulating myeloid cells to improve cancer immunotherapy. Jan 31, 2019 258
Boy, 11, given new genetic cancer drug. Jan 31, 2019 130
Seattle Genetics label expansion likely to drive Q4 beat, says Piper Jaffray. Jan 29, 2019 117
The Effect of TAX-1 Gene of Human T-cell Leukemia Virus Type-1 on the Expression of CCR5 in K562 Cell Line. Sadaghiani, Nasrin Haghnazari; Pirayeshfard, Lila; Aghaie, Afsaneh; Sharifi, Zohreh Report Jan 1, 2019 2910
Navigating the road to digital supply chain transformation. Saenz, Maria Jesus; Cottrill, Ken Jan 1, 2019 1355
Doc: We're fighting cancer..and chemo; Irish expert says our own immune cells are key to conquering disease. Dec 16, 2018 434
Bellicum Pharmaceuticals reports data from BPX-601 at ESMO-IO. Dec 14, 2018 277
Aptevo Therapeutics doses first patient in Phase 1/1b trial of APVO436. Dec 13, 2018 151
Bristol-Myers enters new clinical collaboration with Vedanta Biosciences. Dec 10, 2018 102
United States : Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers. Dec 10, 2018 434
United States : Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas. Dec 8, 2018 715
iCell Gene Therapeutics Presents First-in-Human Data of CLL1-CD33 Compound CAR T in Refractory Acute Myeloid Leukemia. Dec 7, 2018 409
Bluebird bio and Celgene Present Initial Data from Ongoing Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy bb21217 in Patients with Relapsed/Refractory Multiple Myeloma. Dec 6, 2018 754
Unum Therapeutics receives patent for ACTR platform from USPTO. Dec 6, 2018 111
Amgen says AMG420 receives FDA fast track designation. Dec 4, 2018 281
Seattle Genetics' T-cell lymphoma data best case scenario, says William Blair. Dec 4, 2018 119
Fate Therapeutics announces preclinical data on iPSC product platform at ASH. Dec 4, 2018 385
UK's AFH Wealth Management reports asset increase. Dec 3, 2018 241
AbCellera collaborates with Autolus Therapeutics. Dec 3, 2018 238
UK's AFH Wealth Management reports asset increase. Dec 3, 2018 239
AbCellera collaborates with Autolus Therapeutics. Dec 3, 2018 234
VINETI PARTNERS WITH TESSA THERAPEUTICS. Dec 1, 2018 783
Fitch Ratings affirms Catchment Tay Limited's notes. Dec 1, 2018 314
Clinical flow assay. Dec 1, 2018 104
Term ve gec preterm bebeklerde gobek kordonu klempleme zamaninin lenfosit alt gruplari uzerine etkisi/The effects of umblical cord clamping time on lymphocyte subgroups in term and late preterm infants. Bahar, Nilgun; Satar, Mehmet; Yilmaz, Mustafa; Buyukkurt, Selim; Ozlu, Ferda; Yildizdas, Hacer Yapic Report Dec 1, 2018 5124
Fitch Affirms Catchment Tay Limited's Notes at 'BBB-'; Outlook Stable. Nov 30, 2018 967
Impact of T lymphocytes on clinical disease, immune responses and transmission of bluetongue virus in sheep. Nov 29, 2018 281
Dissecting the role of TGF-beta+ regulatory CD4+ T cells in pathogenesis of Marek's disease in chickens. Nov 29, 2018 331
Kura Oncology announces new patent for tipifarnib from USPTO. Nov 28, 2018 160
Celgene, bluebird bio Complete Enrollment of Pivotal KarMMa Study of anti-BCMA Car T Cell Therapy bb2121 in Patients with Relapsed and Refractory Multiple Myeloma. Nov 28, 2018 396
How salt can trigger inflammation in multiple sclerosis. Nov 25, 2018 469
Vineti & Tessa Therapeutics partnership to advance and scale cancer immunotherapies world-wide. Nov 23, 2018 195
Service Of Immunosuppression Of Cell Receptors B (bcrs) And T Cell Receptors (tcrs) By Means Of A New Generation Sequencing Platform, Destined For The Research Group Of Systemic Diseases Of The University Hospital Foundation Hebron Valley - Research Insti. Nov 21, 2018 151
The US FDA approves first-line treatment Adcetris for peripheral T-cell lymphoma under new review pilot. Nov 19, 2018 266
The US FDA approves first-line treatment Adcetris for peripheral T-cell lymphoma under new review pilot. Nov 19, 2018 262
Atara Biotherapeutics announces publication of Phase 1 ATA190 results. Financial report Nov 19, 2018 290
FDA Grants Breakthrough Therapy Designation to Adcetris for Frontline Peripheral T-Cell Lymphomas. Nov 19, 2018 1245
Fundit: Functional diversity of t cells. Nov 17, 2018 378
Cor1-tcell: Analysis of the role for coronin 1-dependent cell density signalling in t-cell homeostasis. Nov 17, 2018 357
Mechanoimm: Mechanical immunoengineering for enhanced t-cell immunotherapy. Nov 17, 2018 361
United States : Seattle Genetics Announces FDA Approval of ADCETRIS (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas. Nov 17, 2018 776
United States : FDA Grants Breakthrough Therapy Designation to ADCETRIS (Brentuximab Vedotin) for Frontline Peripheral T-Cell Lymphomas. Nov 17, 2018 615
United States : Sprint to Launch All-New Sprint LTE Chromebook by CTL for Education and Business Customers. Nov 17, 2018 402
Probiotics can help increase bone density: Study. Nov 16, 2018 360
Amgen receives positive CHMP opinion to expand use of BLINCYTO. Clinical report Nov 16, 2018 104
Seattle Genetics announces FDA approval of ADCETRIS. Nov 16, 2018 478
Probiotics can help increase bone density: Study. Nov 16, 2018 318
Seattle Genetics receives Breakthrough Therapy Designation for ADCETRIS. Nov 15, 2018 309
Probiotics can help increase bone density. Nov 15, 2018 352
Harpoon Therapeutics Launches ProTriTAC Platform: A Novel, Protease-Activated T Cell Engager Platform Designed to Access a Broad Landscape of Solid Tumor Targets. Nov 14, 2018 468
Probiotics can help increase bone density: Study. Nov 14, 2018 331
Harpoon Therapeutics completes USD70m series C equity financing. Nov 13, 2018 181
Harpoon Therapeutics completes USD70m series C equity financing. Nov 13, 2018 177
Compugen announces issuance of U.S. patent for COM902. Nov 13, 2018 139
Cesca Therapeutics subsidiary filed MAF with FDA. Nov 13, 2018 104
Obsidian Presents Preclinical Data Demonstrating Precise Regulation of Cytokines and CAR in T cells with Destabilizing Domain Technology using FDA-Approved Drugs. Nov 13, 2018 447
Ziopharm, Regeneron announce clinical supply agreement for rGBM treatment. Nov 12, 2018 191
Jounce Therapeutics presents data from ICOS program at SITC annual meeting. Nov 11, 2018 340
OncoMed announces early clinical data for anti-TIGIT antibody. Nov 9, 2018 230
Cue Biopharma presents foundational data on Immuno-STAT platform and CUE-101. Nov 9, 2018 219
Vedanta Biosciences Touts Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate. Nov 9, 2018 567
Sensei Biotherapeutics Presents Clinical Trial Data Demonstrating SNS-301 Induces Rapid and Robust Antigen-specific Immune Responses. Nov 9, 2018 743
US FDA receives supplemental Biologics License Application for Seattle Genetics' Adcetris. Nov 7, 2018 194
US FDA receives supplemental Biologics License Application for Seattle Genetics' Adcetris. Nov 7, 2018 190
Seattle Genetics Submits Supplemental Biologics License Application for Adcetris (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas. Nov 7, 2018 480
Provectus says FDA grants orphan drug designation to PV-10 for neuroblastoma. Nov 5, 2018 131
Seattle Genetics submits supplemental BLA for ADCETRIS. Nov 5, 2018 242
United States : Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios. Nov 5, 2018 666
T-cell lymphoma with rhabdomyolysis: case report and literature review. Ouyang, Zhao-Zhong; Peng, Ting-Sheng; Cao, Qing-Hua; Ouyang, Yin; Li, Jun-Xun; Wei, Qiu-Xiang; Zhan, Case study Nov 1, 2018 1550
Kikuchi-Fujimoto Disease: A Review. Perry, Anamarija M.; Choi, Sarah M. Report Nov 1, 2018 3487
Update on Gastrointestinal Lymphomas. Weindorf, Steven C.; Smith, Lauren B.; Owens, Scott R. Report Nov 1, 2018 3437
Primary Cutaneous Composite Lymphomas. Chen, Stephanie; Boyer, Daniel; Hristov, Alexandra C. Report Nov 1, 2018 2922
Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma. Monroig-Bosque, Paloma del C.; Driver, Brandon; Morales-Rosado, Joel A.; Deavers, Michael; Tacha, Da Report Nov 1, 2018 4002
Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis. Chen, Jiazhen; Ruan, Qiaoling; Shen, Yaojie; Wang, Sen; Shao, Lingyun; Zhang, Wenhong Nov 1, 2018 5820
Human T cell lymphotropic virus type 1 infection among men who have sex with men in Central Brazil. Castro, Lisie Souza; Rezende, Grazielli Rocha de; Fernandes, Fernanda Rodas Pires; Bandeira, Larissa Nov 1, 2018 3398
Effects of Topical Thymoquinone in an Experimental Dry Eye Model. Kocaturk, Tolga; Erkan, Erol; Meteoglu, Ibrahim; Ekici, Mehmet; Buyukozturk, Aslihan Karul; Yavasogl Nov 1, 2018 4954
City of Hope opens CAR T trial for patients with HER2-positive breast cancer. Oct 30, 2018 225
Mustang Bio announces initiation of Phase 1 in HER2-positive breast cancer. Oct 30, 2018 228
NanoString, MacroGenics enter translational research collaboration. Oct 29, 2018 170
How insulin boosts immune system. Oct 25, 2018 406
Adaptimmune presents updated data from ongoing MAGE-A10, MAGE-A4 studies. Oct 21, 2018 413
BioLineRx discloses additional data from Phase 2a COMBAT/KEYNOTE-202 study. Oct 21, 2018 244
G1 presents additional data from randomized Phase 2 trial in first-line SCLC. Oct 21, 2018 161
Fine Particulate Matter-Induced Exacerbation of Allergic Asthma via Activation of T-cell Immunoglobulin and Mucin Domain 1. Zhao, Yun-Xia; Zhang, Hui-Ran; Yang, Xiu-Na; Zhang, Yu-Hao; Feng, Shan; Yu, Feng-Xue; Yan, Xi-Xin Report Oct 20, 2018 10257
United Kingdom,United States : First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT). Oct 20, 2018 254
Innovent Biologics Inc treats first patient in phase I clinical trial of anti-CTLA-4 monoclonal antibody (IBI310). Oct 19, 2018 208
Innovent Biologics Inc treats first patient in phase I clinical trial of anti-CTLA-4 monoclonal antibody (IBI310). Oct 19, 2018 204
Five Prime Therapeutics Initiates Patient Dosing in The Dose Exploration Cohort of Its Phase 1 Trial of Novel First-in-class B7-H4 Antibody FPA150. Oct 18, 2018 441
Applied DNA Sciences subsidiary LineaRx licenses CAR T candidate. Oct 16, 2018 109
Five Prime initiates patient dosing in dose exploration cohort of Phase 1 trial. Oct 16, 2018 258
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform. Oct 16, 2018 393
Soligenix receives DMC recommendation to enroll more subjects in FLASH study. Oct 15, 2018 310
Athenex announces preliminary results from TAEST pilot studies. Oct 15, 2018 359
United States : Ziopharm and Precigen Redefine Relationships, Announce New License Agreement. Oct 15, 2018 643
Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy. Oct 11, 2018 314
G1 Therapeutics announces new data from Phase 2 trilaciclib trial at ESMO. Oct 9, 2018 120
Ziopharm, Intrexon subsidiary announce new definitive license agreement. Oct 9, 2018 246
Supply Of 1 Cell Processing Equipment And Consumables Necessary For The Automated Manufacture Of Cart-t Cells And Other Cell Therapy Products In Banco Sangre Tejidos Cantabria. Oct 9, 2018 149
FDA puts Affimed N.V.'s AFM11 phase 1 program on hold following death of patient. Oct 8, 2018 212
Adaptimmune to present updates from MAGE-A10 studies at ESMO. Oct 8, 2018 165
United States : Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma. Financial report Oct 6, 2018 716
Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. Oct 4, 2018 205
Daiichi Sankyo's axicabtagene ciloleucel granted Orphan Drug designation by Japanese Ministry. Oct 4, 2018 201
PD-L1 Biomarker Testing Market Higher Mortality Rates by 2027. Oct 4, 2018 1179
PD-L1 Biomarker Testing Market to Gain a Stronghold by 2027. Oct 4, 2018 1179
PD-L1 Biomarker Testing Market Likely to Emerge over a Period of 2017-2027. Oct 4, 2018 1179
IBBR receives $1.2M NIH award to develop 3D modeling tool. Oct 3, 2018 252
United States : Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer. Oct 3, 2018 322
Kite, HiFiBiO announce research collaboration. Oct 2, 2018 186
Inovio spikes higher after positive data published. Oct 2, 2018 332
Seattle Genetics, Takeda Tout Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating Adcetris in Frontline CD30-Expressing Peripheral T-Cell Lymphoma. Oct 2, 2018 1050
Actinium Pharmaceuticals launches Iomab-ACT program. Oct 1, 2018 157
KSQ Therapeutics Secures USD 80m Financing and Advances Pipeline of Cancer Therapies. Oct 1, 2018 536
Candidiasis mucocutanea cronica: una mirada al entendimiento genetico. Maya-Rico, Ana Maria; Cardona-Castro, Nora Oct 1, 2018 3585
Fate, ONO Pharmaceutical. Oct 1, 2018 323
St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration. Sep 30, 2018 596
Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies. Sep 30, 2018 797
First Patient Dosed With FLX475, an CCR4 Inhibitor for the Treatment of Multiple Cancers. Sep 28, 2018 483
United States : BLINCYTO (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia. Sep 27, 2018 640
Cellular signs licensing and collaboration agreement with Novartis in China. Sep 27, 2018 114
Terex extends maximum jib length with new luffer tower crane. Sep 26, 2018 552
Regen BioPharma announces activation of immune cells by NR2F6. Sep 24, 2018 178
Regen BioPharma announces activation of immune cells by NR2F6. Sep 24, 2018 174
Cancer Immunotherapy: Overlooked Immune Players. Sep 24, 2018 1107
Supply Of Human Cd4 Microbeads, 2ml, Humancd45ra Microbeads, 2ml, Cd4 T Cell Isolation Kit, Mouse And Bdca4/neutropilin 1 Microbead Kit, Human. Sep 21, 2018 150
Fate Therapeutics to partner with ONO Pharma on Car-T cell immunotherapy. Sep 17, 2018 232
Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). Sep 11, 2018 266
Innovent Biologics treats first patient under phase III clinical trial of sintilimab for non-squamous non-small cell lung cancer (NSCLC). Sep 11, 2018 262
Amgen's AMG420 risk overstated, says Wells Fargo. Sep 11, 2018 156
Triumvira Inks License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates. Sep 10, 2018 401
T cell behavior has major implications for cancer immunotherapy. Sep 8, 2018 523
Protein that enhances vaccine efficacy identified. Sep 8, 2018 332
Biothera Pharmaceuticals enters into collaboration with AstraZeneca. Sep 7, 2018 180
Biothera Pharmaceuticals enters into collaboration with AstraZeneca. Sep 7, 2018 176
'Game changing' cancer therapy on offer in Newcastle. Sep 6, 2018 497
Hospital to offer new leukaemia therapy. Sep 6, 2018 620
Atara Biotherapeutics enters into CAR T collaboration with Moffitt Cancer Center. Sep 6, 2018 203
Amedica sells spine business to CTL Medical for $10M. Sep 6, 2018 214
Early Changes in Circulatory T Helper Type 1, 2, and 17 Cells of Patients with Out-of-Hospital Cardiac Arrest after Successful Cardiopulmonary Resuscitation. Qi, Zhi-Jiang; Zhang, Qiang; Liu, Bo; Shao, Huan; Li, Chun-Sheng Report Sep 5, 2018 5110
Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation. Huang, Wen-Rong; Liu, Dai-Hong Report Sep 5, 2018 6001
Pricy process is unique to each tumour. Sep 5, 2018 116
NHS gives 'chance of a leukaemia cure to kids who have no other hope'. Sep 5, 2018 324
Expensive as it is unique to each tumour. Sep 5, 2018 116
Costly as it is tailor-made to each tumour. Sep 5, 2018 116
Young cancer victims among first to get pioneering new treatment on NHS; The NHS is set to announce today that it will become the first health service in Europe to offer full access to the immunotherapy called CAR-T. Sep 5, 2018 482
Aduro Biotech announces data publication on APRIL in MM in Leukemia. Sep 4, 2018 260
Imbalance of [gamma][delta]T17/[gamma][delta]Treg cells in the pathogenesis of allergic asthma induced by ovalbumin. Yang, Xia; Zhang, Jing-Hong; Deng, Wang-Sheng; Li, Chao-Qian Report Sep 1, 2018 3950
Mycosis fungoides. Martin, Donna Bilu Sep 1, 2018 474
Cutavirus shows no association with primary cutaneous lymphoma. Splete, Heidi Sep 1, 2018 245
Mesenchymal stem cells prolong the survival of orthotopic liver transplants by regulating the expression of TGF-[beta]1. Niu, Jian; Wang, Yue; Liu, Bin; Yao, Yuanhu Sep 1, 2018 5197
Perforation of the small intestine caused by enteropathy-associated T cell lymphoma. Kabul, Selva; Ugras, Nesrin; Yerci, Omer; Ozturk, Ersin Sep 1, 2018 1532
HIV ile Enfekte Olgularin Bagirsak Protozoonlari Acisindan Retrospektif Olarak Incelenmesi/Intestinal Protozoa in HIV-infected Patients: A Retrospective Analysis. Zorbozan, Orcun; Quliyeva, Gunel; Tunali, Varol; Ozbilgin, Ahmet; Turgay, Nevin; Gokengin, Ayse Deni Report Sep 1, 2018 2390
Regeneron, bluebird bio. Sep 1, 2018 343
CTL: Thompson. Sep 1, 2018 113
T cell reactivity to Collagen II as a possible prognostic marker in patients with rheumatoid arthritis. Aug 31, 2018 3675
How insulin boosts immune system. Aug 31, 2018 406
Singapore's First Clinical Trial Approval for T-cell Engineered (TCR) Immunotherapy for Treatment of Liver Cancer. Aug 31, 2018 475
The European Commission approves Novartis' Kymriah CAR-T cell therapy. Aug 29, 2018 212
The European Commission approves Novartis' Kymriah CAR-T cell therapy. Aug 29, 2018 208
CStone receives CNDA approval for anti-CTLA-4 antibody CS1002. Aug 28, 2018 229
CStone receives CNDA approval for anti-CTLA-4 antibody CS1002. Aug 28, 2018 225
United States : Yescarta (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL, After Two or More Lines of Systemic Therapy. Aug 28, 2018 521
Novartis receives EC approval for Kymriah. Aug 27, 2018 129
For hospitals, being first means they have what it takes. Daks, Martin Aug 27, 2018 1281
Bluebird Bio and Gritstone Oncology Team to Develop Novel Cancer Cell Therapies. Aug 24, 2018 476
Soligenix receives U.S. patent for synthetic hypericin used in SGX301. Aug 22, 2018 116
Batu Biologics Identifies Gene Types Associated with Response to ValloVax. Aug 22, 2018 229
Immunocore doses first patient in phase I study of IMCnyeso. Aug 21, 2018 181
Immunocore doses first patient in phase I study of IMCnyeso. Aug 21, 2018 177
Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. Aug 20, 2018 169
Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. Aug 20, 2018 284
Singapore's Health Sciences Authority approves Lion TCR's Phase I/II multicentre clinical study of LioCyx. Aug 20, 2018 173
Lion TCR Pte Ltd approves first clinical trial for T cell engineered (TCR) immunotherapy in Singapore for treatment of liver cancer. Aug 20, 2018 288
Eureka Therapeutics Highlights Publication of Armored T-Cell Proof-of-Concept Study in Nature Biotechnology. Aug 20, 2018 530
Study: Glaucoma may be an autoimmune disease. Aug 15, 2018 292
Adaptimmune to initiate third dosing cohort in MAGE-A4 SPEAR T-cell study. Aug 15, 2018 114
RXi Pharmaceuticals and Swedish institute partner to develop sd-rxRNA compounds. Aug 15, 2018 107
Scancell Holdings, Karolinska Institute Sweden expand research collaboration. Aug 13, 2018 188
Scancell Holdings, Karolinska Institute Sweden expand research collaboration. Aug 13, 2018 184
Unum Therapeutics announces IND activation for ACTR T cells with trastuzumab. Aug 13, 2018 124
United States : Bluebird Bio Forms Strategic Collaboration With Regeneron to Make New Cell Therapies for Cancer. Aug 13, 2018 221
Glaucoma May Be an Autoimmune Disease. Aug 11, 2018 902
Moleculin Biotech seeks approval from Polish agency for skin cancer trial. Aug 9, 2018 155
Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients. Aug 9, 2018 439
Ziopharm reports Q2 EPS (12c), consensus (12c). Financial report Aug 8, 2018 101
Caramba: Slamf7-car t cells prepared by sleeping beauty gene-transfer for immunotherapy of multiple myeloma a rare hematologic disease. Aug 8, 2018 468
Basilic: Decoding at systems-level the crosstalk between the t cell antigen receptor, The cd28 costimulator and the pd-1 coinhibitor under physiological and pathological conditions. Aug 7, 2018 385
Germany : Can rare lymphocytes combat rheumatoid arthritis? Aug 7, 2018 564
Regeneron, Bluebird Bio announce collaboration. Aug 6, 2018 254
Miragen Therapeutics, LLS enter agreement to support development of cobomarsen. Aug 6, 2018 182
CenturyLink authorised to operate under GSA Alliant 2. Aug 6, 2018 246
CenturyLink authorised to operate under GSA Alliant 2. Aug 6, 2018 234
CenturyLink authorised to operate under GSA Alliant 2. Aug 6, 2018 246
New Combinations Of Immune-checkpoint Inhibitors To Treat Cancer. Aug 3, 2018 502
Kite, Gadeta Forge Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors. Aug 2, 2018 463
Gene linked to hair loss may improve cancer treatment. Aug 2, 2018 350

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters